Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.

about

Inflammation in Vein Graft Disease.

P2860

Q50127096-5A4BDC0B-92E0-45F8-AE75-4BEFDBB050A9

P2860

Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.

Item

http://www.wikidata.org/entity/Q41074576

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Advanced glycation end product ...... ignalling pathway in diabetes.

@en

type

Item

label

Advanced glycation end product ...... ignalling pathway in diabetes.

@en

prefLabel

Advanced glycation end product ...... ignalling pathway in diabetes.

@en

P1476

Advanced glycation end product ...... ignalling pathway in diabetes.

@en

P2093

Chunsheng Wang

http://www.w3.org/2001/XMLSchema#string

Huan Liu

http://www.w3.org/2001/XMLSchema#string

Jun Li

http://www.w3.org/2001/XMLSchema#string

Le Kang

http://www.w3.org/2001/XMLSchema#string

Yongxin Sun

http://www.w3.org/2001/XMLSchema#string

Yulin Wang

http://www.w3.org/2001/XMLSchema#string

Yunzeng Zou

http://www.w3.org/2001/XMLSchema#string

P2860

ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells

Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia.

Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.

Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo

Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function

The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model.

Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting.

Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.

Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

RAGE biology, atherosclerosis and diabetes.

P304

1945-1955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.12886

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27297874

http://www.w3.org/2001/XMLSchema#string

P932

5020631

http://www.w3.org/2001/XMLSchema#string

Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.

about

P2860

P2860

Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932